CClinicalTrials.gg
CompletedNCT01779440Updated Jun 27, 2018Results posted

Decision Support for Smoking Cessation in Young Adults With Severe Mental Illness

An interventional study of Electronic Decision Support System in Mental Illness, Tobacco Smoking and Psychotic Disorders, sponsored by Dartmouth-Hitchcock Medical Center. Completed at 3 sites in United States. Open to participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2018-06-27.

Sponsored by Dartmouth-Hitchcock Medical Center · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
58
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

Up to 77% of young people with severe mental illnesses smoke, a rate that is up to five times higher than the rate of daily smoking in other young adults. Contrary to popular belief, smoking tobacco does not provide any benefit for mental illness symptom control. People with severe mental illnesses (SMI: schizophrenia and severe mood disorders) are dying, on average, 25 years earlier than those without SMI. Much of this early mortality is due to higher rates of heart and lung diseases, cancers, strokes, and diabetes.

Cessation of smoking in these transition-age young adults can prevent cancer and increase life expectancy to that of non-smokers. Combination treatments are effective in this group and therefore key to improving outcomes, but few SMI smokers use them despite their interest in quitting. Motivational interventions for cessation increase interest in quitting, but public mental health clinicians do not deliver them, in part due to economic reasons. Thus cost effective methods to deliver motivational interventions to engage young smokers with SMI into treatment are needed.

To address this gap, we have developed an electronic decision support system (EDSS) for smoking cessation that is specifically tailored for smokers with SMI, who tend to have cognitive deficits and limited computer experience. Similar to EDSSs developed for other health problems, this EDSS provides information and motivational exercises within an easy-to-use, web-based computer program that can be used with minimal or no staff assistance. Initial piloting of the EDSS in middle-aged SMI smokers showed excellent usability and promising efficacy. Pilot-testing among young patients suggested that the EDSS increased motivation to quit smoking and provided direction to adapt the format and content of the EDSS for young SMI smokers.

The purpose of this proposal is to further develop the motivational decision support system and to test its ability to motivate young smokers with SMI to quit smoking with cessation treatment.

Read the detailed description

The research will take place over 2 years at the Long Island Zucker Hillside Hospital system. In Year 1, we will adapt our electronic decision support system, a web-based motivational tool, for young smokers with severe mental illness. We will first identify beliefs of young smokers with severe mental illness that impede use of smoking cessation treatments. Then, the decision support system will be revised to change these beliefs, field-tested for usability, and improved as needed. In Year 2, we will conduct a randomized control trial of the newly revised version of the system among 60 young smokers with severe psychotic disorders.

In the controlled trial, participants will be assessed at baseline for mental health symptoms and smoking behavior and history, and then randomized to use the system or a computerized public health pamphlet (control condition) within two weeks. Participants will be assessed again at 14-week follow-up for clinician-confirmed initiation of smoking cessation treatment (main outcome), beliefs, and smoking characteristics. Analyses will assess whether use of the decision support system results in greater initiation of cessation treatment (main outcome), and changes in beliefs about treatment, than use of the control intervention.

02

Conditions studied

  • Mental Illness
  • Tobacco Smoking
  • Psychotic Disorders

Keywords

  • Mental Illness
  • Tobacco Smoking
  • Young Adults
  • Treatment Engagement
  • Motivational Intervention
03

In context

Mental Disorders

2,107 studies on the registry are indexed under Mental Disorders; 416 are open to participants now.

This study's enrollment of 58 is below the median of 94 across 1,574 interventional studies indexed under Mental Disorders.

Browse Mental Disorders studies →

Lead sponsor

Dartmouth-Hitchcock Medical Center is the lead sponsor of 472 studies on the registry; 68 are open to participants now.

Of its 30 completed or terminated interventional studies of FDA-regulated products, 20 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

English-speaking; non-pregnant/nursing; daily smokers; age 18-30; psychiatrically stable; in treatment in the Zucker Hillside Hospital system; diagnosed with SMI (schizophrenia, schizoaffective disorder, or mood disorder with psychotic features from medical chart); willing and able to give informed consent.

Exclusion criteria

Exclusion Criteria:

(Phase 4 only): current (within the past month) use of evidence-based smoking cessation treatment (indicating the subject is already motivated), psychiatric instability (Modified Colorado Symptom Index score >45), current untreated substance use disorder (SUD)

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
58 participants (actual)

Study arms

  • Other
    Electronic Decision Support System

    The Electronic Decision Support System is a web-based computer program designed to motivate, educate, and engage people with severe mental illness into evidence-based smoking cessation treatment.

    Behavioral: Electronic Decision Support System

  • Placebo comparator
    Control Computer Program

    A computer program aimed to educate people about smoking cessation treatment.

    Behavioral: Electronic Decision Support System

Interventions

  • BehavioralElectronic Decision Support System
06

What researchers measure

Primary outcomes

  1. Number of Participants Who Utilized Smoking Cessation Treatment

    Assesses through clinician confirmation any engagement in behavioral smoking cessation treatment and/or smoking cessation medication treatment.

    Time frame: 14 week follow-up

Secondary outcomes

  1. Number of Participants With Biologically Confirmed Abstinence

    Abstinence - self report for past 7 days confirmed with breath Carbon Monoxide \<9 ppm

    Time frame: 14 weeks

07

Results

Posted Jun 27, 2018

Participant flow

Participant flow — Overall Study
MilestoneElectronic Decision Support SystemControl Computer Program
Started3028
Completed2723
Not completed35
Withdrew: Withdrawal by subject35

Outcome measures

PrimaryNumber of Participants Who Utilized Smoking Cessation Treatment

Assesses through clinician confirmation any engagement in behavioral smoking cessation treatment and/or smoking cessation medication treatment.

Time frame:
14 week follow-up
Reported as:
Count of participants · Participants
Number of Participants Who Utilized Smoking Cessation Treatment
ParticipantsElectronic Decision Support SystemControl Computer Program
Number of Participants Who Utilized Smoking Cessation Treatment21
Statistical analysis
  • Electronic Decision Support System vs Control Computer Program · Chi-squared · p = 0.65 (The P-Value of 0.65 was calculated from the difference between groups for the above outcome variable.)
SecondaryNumber of Participants With Biologically Confirmed Abstinence

Abstinence - self report for past 7 days confirmed with breath Carbon Monoxide \<9 ppm

Time frame:
14 weeks
Reported as:
Count of participants · Participants
Number of Participants With Biologically Confirmed Abstinence
ParticipantsElectronic Decision Support SystemControl Computer Program
Number of Participants With Biologically Confirmed Abstinence40

Adverse events

Collected over 14 weeks. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Electronic Decision Support System0/30 (0%)0/30 (0%)0/30 (0%)
Control Computer Program0/28 (0%)0/28 (0%)0/28 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Electronic Decision Support SystemControl Computer ProgramTotal
Mean23.5 ± 3.925.0 ± 3.224.2 ± 3.4
Sex: Female, Male
Sex: Female, Male(Participants)Electronic Decision Support SystemControl Computer ProgramTotal
Female10919
Male201939
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Electronic Decision Support SystemControl Computer ProgramTotal
Caucasian171633
African American91019
Other race426
Mean cigarettes per day
Mean cigarettes per day(cigarettes)Electronic Decision Support SystemControl Computer ProgramTotal
Mean10.9 ± 8.613.9 ± 9.412.3 ± 9.0
08

Study locations

3 sites
  • Mental Health Center of Greater Manchester
    Manchester, New Hampshire 03103, United States
  • Greater Nashua Mental Health Center
    Nashua, New Hampshire 03060, United States
  • Zucker-Hillside Hospital
    Glen Oaks, New York 11004, United States
09

References and documents

Publications

  • Brunette MF, Feiron JC, Aschbrenner K, Colctti D, Devitt T, Greene MA, Harrington A, MoHugo GC, Pratt S, Robinson D, Williams J, Xie H. Characteristics and Predictors of Intention to use Cessation Treatment among Smokers with Schizophrenia: Young Adults Compared to Older Adults. J Subst Abus Alcohol. 2017;5(1):1055. Epub 2017 Mar 23. PubMed 29881770 ↗
  • Brunette MF, Ferron JC, Robinson D, Coletti D, Geiger P, Devitt T, Klodnick V, Gottlieb J, Xie H, Greene MA, Ziedonis D, Drake RE, McHugo GJ. Brief Web-Based Interventions for Young Adult Smokers With Severe Mental Illnesses: A Randomized, Controlled Pilot Study. Nicotine Tob Res. 2018 Sep 4;20(10):1206-1214. doi: 10.1093/ntr/ntx190. PubMed 29059417 ↗

Study documents

  • Study protocol · Nov 24, 2015
  • Statistical analysis plan · Nov 24, 2015

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 27, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01779440
Lead sponsor
Dartmouth-Hitchcock Medical Center
Collaborators
National Cancer Institute (NCI)
Responsible party
Mary F. Brunette, MD (Associate Professor MD, Dartmouth-Hitchcock Medical Center) — Principal investigator
First posted
Jan 30, 2013
Start date
Jan 1, 2013
Primary completion
Feb 22, 2018
Completion
Feb 22, 2018
Results posted
Jun 27, 2018
Last update
Jun 27, 2018

Study contacts

Mary F. Brunette, MD
principal investigator · Dartmouth College

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion